Nicole Buschmann

Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors

Philipp Holzer, Keiichi Masuya, Pascal Furet et al. · Journal of Medicinal Chemistry · 2015 · 202 citations · Full text

Dihydroisoquinolinone Derivative, Drug Target, Molecular Biology +18

Synthesis and Application of a Permanently Immobilized Olefin-Metathesis Catalyst

Stephan C. Schürer, Simon Gessler, Nicole Buschmann et al. · Angewandte Chemie International Edition · 2000 · 185 citations

Chemical Engineering, Engineering, Alkene Metathesis +9

Ruthenium olefin metathesis catalysts with modified styrene ethers: influence of steric and electronic effects

Mirko Zaja, Stephen J. Connon, Aideen M. Dunne et al. · Tetrahedron · 2003 · 139 citations

Materials Science, Engineering, Alkene Metathesis +8

Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4

Robin A. Fairhurst, Thomas Knoepfel, Nicole Buschmann et al. · Journal of Medicinal Chemistry · 2020 · 106 citations · Full text

Reversible-covalent Inhibitor, Molecular Pharmacology, Signaling Pathway +19

Hydroboration and Suzuki–Miyaura Coupling Reactions with the Electronically Modulated Variant of an Ynamine: The Synthesis of (E)-β-Arylenamides

B. Witulski, Nicole Buschmann, Uwe Bergsträßer · Tetrahedron · 2000 · 103 citations

Materials Science, Cross-coupling Reaction, Engineering +7